Biodesix Financial Statements From 2010 to 2025

BDSX Stock  USD 1.04  0.01  0.95%   
Biodesix financial statements provide useful quarterly and yearly information to potential Biodesix investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Biodesix financial statements helps investors assess Biodesix's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Biodesix's valuation are summarized below:
Gross Profit
51 M
Profit Margin
(0.67)
Market Capitalization
151.3 M
Enterprise Value Revenue
2.7957
Revenue
65.6 M
We have found one hundred twenty available fundamental signals for Biodesix, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Biodesix prevailing market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road. Market Cap is likely to drop to about 105.8 M in 2025. Enterprise Value is likely to drop to about 93.5 M in 2025

Biodesix Total Revenue

42.6 Million

Check Biodesix financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biodesix's main balance sheet or income statement drivers, such as Interest Income of 25.9 K, Depreciation And Amortization of 3.2 M or Interest Expense of 6.5 M, as well as many indicators such as Price To Sales Ratio of 3.36, Dividend Yield of 0.0 or PTB Ratio of 31.17. Biodesix financial statements analysis is a perfect complement when working with Biodesix Valuation or Volatility modules.
  
Check out the analysis of Biodesix Correlation against competitors.
For more information on how to buy Biodesix Stock please use our How to Invest in Biodesix guide.

Biodesix Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets86.1 M114 M61.4 M
Slightly volatile
Short and Long Term Debt Total73.3 M69.8 M32.3 M
Slightly volatile
Other Current Liabilities36.1 M34.3 M11.6 M
Slightly volatile
Total Current Liabilities26.5 M38.4 M15.3 M
Slightly volatile
Other Liabilities19.8 M17.3 M24 M
Slightly volatile
Property Plant And Equipment Net35.8 M34.1 M8.1 M
Slightly volatile
Current Deferred Revenue277 K291.6 K809.2 K
Pretty Stable
Accounts Payable3.3 M3.4 MM
Slightly volatile
Cash32.2 M30.2 M17.8 M
Slightly volatile
Non Current Assets Total41.2 M68.3 M35.4 M
Slightly volatile
Non Currrent Assets Other8.3 M7.9 M2.2 M
Slightly volatile
Other Assets7.2 M6.8 MM
Slightly volatile
Long Term Debt24.4 M40.5 M23.9 M
Slightly volatile
Cash And Short Term Investments32.2 M30.2 M17.8 M
Slightly volatile
Net Receivables7.1 M8.8 M4.4 M
Slightly volatile
Good Will15.1 M17.3 M12.6 M
Slightly volatile
Common Stock Total Equity32.6 K31.1 K11.4 K
Slightly volatile
Common Stock Shares Outstanding99.2 M94.4 M37.9 M
Slightly volatile
Liabilities And Stockholders Equity86.1 M114 M61.4 M
Slightly volatile
Non Current Liabilities Total88.8 M55 M166.9 M
Slightly volatile
Inventory1.9 M1.6 M1.2 M
Slightly volatile
Other Current Assets4.1 MMM
Slightly volatile
Other Stockholder Equity286.9 M487.7 M150 M
Slightly volatile
Total Liabilities108 M85.1 M181.3 M
Slightly volatile
Property Plant And Equipment Gross42.5 M40.5 M9.3 M
Slightly volatile
Total Current Assets45 M45.6 M26 M
Slightly volatile
Capital Stock115.9 K110.4 K29.3 K
Slightly volatile
Non Current Liabilities Other608.8 K640.8 K20.5 M
Slightly volatile
Intangible Assets9.9 M7.1 M14.2 M
Slightly volatile
Common Stock115.9 K110.4 K29.3 K
Slightly volatile
Property Plant Equipment10.7 M10.1 M3.8 M
Slightly volatile
Short and Long Term Debt43.6 K45.9 K8.4 M
Slightly volatile
Short Term Debt259.1 K272.7 K8.6 M
Slightly volatile
Deferred Long Term Liabilities523.2 K588.6 K641.7 K
Slightly volatile

Biodesix Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Income25.9 K16.2 K24.1 K
Pretty Stable
Depreciation And Amortization3.2 M6.3 M2.6 M
Slightly volatile
Interest Expense6.5 M11 M4.8 M
Slightly volatile
Selling General Administrative49.7 M77.9 M37.9 M
Slightly volatile
Selling And Marketing Expenses44.7 M70.7 M36.7 M
Slightly volatile
Total Revenue42.6 M56.5 M30.9 M
Slightly volatile
Gross Profit26.1 M41.5 M21.1 M
Slightly volatile
Other Operating Expenses78.2 M104 M57.3 M
Slightly volatile
Research Development12 M11.5 M9.6 M
Slightly volatile
Cost Of Revenue16.5 M15 M9.8 M
Slightly volatile
Total Operating Expenses61.6 M89 M47.5 M
Slightly volatile
Reconciled Depreciation4.1 M6.7 M2.9 M
Slightly volatile
Income Tax Expense5.1 M6.1 M2.5 M
Slightly volatile

Biodesix Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation3.7 M6.2 MM
Slightly volatile
Begin Period Cash Flow28.5 M49.7 M17.3 M
Slightly volatile
DepreciationM6.3 M2.9 M
Slightly volatile
Other Non Cash Items7.8 M8.2 M6.8 M
Slightly volatile
Capital Expenditures27.8 M26.5 M5.8 M
Slightly volatile
Issuance Of Capital Stock41 M65.4 M24.9 M
Slightly volatile
Total Cash From Financing Activities38.9 M33.5 M27.3 M
Slightly volatile
End Period Cash Flow32.3 M30.3 M18 M
Slightly volatile
Change To Netincome22.9 M21.8 M10.1 M
Slightly volatile
Sale Purchase Of Stock486.2 K739.5 K385 K
Slightly volatile
Dividends Paid534 K739.5 K406 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio3.363.5411.8741
Slightly volatile
Days Sales Outstanding66.9265.6648.0013
Slightly volatile
Stock Based Compensation To Revenue0.06020.09850.0416
Slightly volatile
Capex To Depreciation3.963.771.1108
Slightly volatile
EV To Sales4.134.3512.4763
Slightly volatile
Inventory Turnover6.768.367.2601
Slightly volatile
Days Of Inventory On Hand49.3645.1751.7291
Slightly volatile
Payables Turnover5.624.05.7232
Pretty Stable
Sales General And Administrative To Revenue1.391.441.2798
Slightly volatile
Research And Ddevelopement To Revenue0.340.230.3513
Slightly volatile
Capex To Revenue0.440.420.1154
Slightly volatile
Cash Per Share0.270.290.4782
Slightly volatile
Days Payables Outstanding86.3294.577.426
Very volatile
Income Quality0.70.50.653
Slightly volatile
Intangibles To Total Assets0.450.270.5511
Slightly volatile
Current Ratio1.931.371.9713
Slightly volatile
Receivables Turnover8.677.359.3546
Slightly volatile
Graham Number0.981.039.4423
Slightly volatile
Capex Per Share0.270.250.0828
Slightly volatile
Revenue Per Share1.280.690.9421
Slightly volatile
Interest Debt Per Share1.130.981.0079
Very volatile
Debt To Assets0.510.70.5446
Pretty Stable
Operating Cycle11611199.7304
Pretty Stable
Days Of Payables Outstanding86.3294.577.426
Very volatile
Ebt Per Ebit1.011.141.1636
Pretty Stable
Quick Ratio1.841.321.8532
Slightly volatile
Net Income Per E B T0.891.111.0535
Slightly volatile
Cash Ratio0.980.711.2233
Pretty Stable
Cash Conversion Cycle21.7912.7821.572
Slightly volatile
Days Of Inventory Outstanding49.3645.1751.7291
Slightly volatile
Days Of Sales Outstanding66.9265.6648.0013
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.981.811.153
Slightly volatile
Fixed Asset Turnover1.811.9111.3221
Slightly volatile
Debt Ratio0.510.70.5446
Pretty Stable
Price Sales Ratio3.363.5411.8741
Slightly volatile
Asset Turnover0.570.49530.5273
Very volatile
Gross Profit Margin0.70.850.7302
Slightly volatile

Biodesix Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap105.8 M111.4 M289.9 M
Slightly volatile
Enterprise Value93.5 M98.4 M291.6 M
Slightly volatile

Biodesix Fundamental Market Drivers

Cash And Short Term Investments26.3 M

Biodesix Upcoming Events

4th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
4th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Biodesix Financial Statements

Biodesix investors use historical fundamental indicators, such as Biodesix's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Biodesix. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue291.6 K277 K
Total Revenue56.5 M42.6 M
Cost Of Revenue15 M16.5 M
Stock Based Compensation To Revenue 0.10  0.06 
Sales General And Administrative To Revenue 1.44  1.39 
Research And Ddevelopement To Revenue 0.23  0.34 
Capex To Revenue 0.42  0.44 
Revenue Per Share 0.69  1.28 
Ebit Per Revenue(0.76)(0.80)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Biodesix Stock Analysis

When running Biodesix's price analysis, check to measure Biodesix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biodesix is operating at the current time. Most of Biodesix's value examination focuses on studying past and present price action to predict the probability of Biodesix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biodesix's price. Additionally, you may evaluate how the addition of Biodesix to your portfolios can decrease your overall portfolio volatility.